2 September 2020
Latham Advises the Underwriters in Immunovant’s Public Offering of Common Stock
Advising firms
Deal team
5 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | capital markets | New York |
| Shayne Kennedy | Latham & Watkins LLP | Partner | capital markets | Orange County |
| Katherine Lovejoy | Latham & Watkins LLP | Associate | capital markets | New York |
| Tina Jeon | Latham & Watkins LLP | Associate | capital markets | New York |
| Egzon Sulejmani | Latham & Watkins LLP | Associate | capital markets | New York |
2 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 174m (US$173.9 million)
- What the figure measures
- Issue size
- Client
- Latham & WatkinsUnderwriters
- Counterparties
- Immunovant, Inc. (Issuer)